Ancora Advisors, LLC Eli Lilly & CO Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ancora Advisors, LLC holds 2,206 shares of LLY stock, worth $1.72 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,206

Previous 6,816 67.63%

Holding current value

$1.72 Million

Previous $6.17 Million 68.34%

% of portfolio

0.05%

Previous 0.17%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $3.56 Million - $4.43 Million	-4,610 Reduced 67.63%	2,206 $1.95 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $38,418 - $48,179	53 Added 0.78%	6,816 $6.17 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $30,794 - $41,198	52 Added 0.77%	6,763 $5.26 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $117,642 - $138,685	-224 Reduced 3.23%	6,711 $3.91 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $86,070 - $118,661	198 Added 2.94%	6,935 $3.72 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $19,290 - $25,793	55 Added 0.82%	6,737 $3.16 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $63,989 - $75,152	-206 Reduced 2.99%	6,682 $2.29 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $263,992 - $307,604	821 Added 13.53%	6,888 $2.52 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $40,321 - $45,950	136 Added 2.29%	6,067 $1.96 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $28,987 - $34,036	104 Added 1.78%	5,931 $1.92 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $54,213 - $67,373	-231 Reduced 3.81%	5,827 $1.67 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $17,367 - $21,582	-74 Reduced 1.21%	6,058 $1.13 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $5,621 - $6,976	-25 Reduced 0.41%	6,132 $1.69 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $21,938 - $26,998	99 Added 1.63%	6,157 $1.42 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $3,122 - $4,041	19 Added 0.31%	6,058 $1.13 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $4,174 - $5,524	-32 Reduced 0.53%	6,039 $1.02 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $31,729 - $36,701	217 Added 3.71%	6,071 $899,000
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $20,076 - $21,838	188 Added 3.32%	5,854 $655,000
Q4 2018 Feb 15, 2019	SELL	$105.9 - $118.64 $54,114 - $60,625	-511 Reduced 8.27%	5,666 $656,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $259,468 - $324,290	3,022 Added 95.78%	6,177 $663,000
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $82,891 - $95,133	-1,095 Reduced 25.76%	3,155 $269,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $416,243 - $491,348	-5,609 Reduced 56.89%	4,250 $329,000
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $253,522 - $271,931	3,094 Added 45.74%	9,859 $833,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $521,378 - $578,678	6,765	6,765 $578,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Eli Lilly & CO Transaction History